If this SPL has inactivated NDCs outlined via the FDA initiated compliance motion, they will be specified as a result. INDICATIONS AND Utilization Hydromorphone hydrochloride extended-release tablets are an opioid agonist indicated for your management of serious and persistent soreness that requi